Rifampicin in treating S aureus bacteraemia - Authors' reply

Rifampicin in treating S aureus bacteraemia - Authors' reply

Bibliografische gegevens
Hoofdauteurs:	Thwaites, G, Szubert, A, Walker, A
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Elsevier 2018

Gelijkaardige items

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT
door: Thwaites, GE, et al.
Gepubliceerd in: (2018)

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT
door: Guy E Thwaites, et al.
Gepubliceerd in: (2018-10-01)

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
door: Thwaites, GE, et al.
Gepubliceerd in: (2017)

Clinical management of Staphylococcus aureus bacteraemia.
door: Thwaites, G, et al.
Gepubliceerd in: (2011)

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.
door: Thwaites, G, et al.
Gepubliceerd in: (2012)

Predictors of recurrence, early treatment failure and death from Staphylococcus aureus bacteraemia: observational analyses within the ARREST trial
door: Szubert, AJ, et al.
Gepubliceerd in: (2019)

Clinical sub-phenotypes of Staphylococcus aureus bacteraemia
door: Swets, MC, et al.
Gepubliceerd in: (2024)

Adjunctive rifampicin to reduce early mortality from <it>Staphylococcus aureus</it> bacteraemia (ARREST): study protocol for a randomised controlled trial
door: Thwaites Guy, et al.
Gepubliceerd in: (2012-12-01)

Staphylococcus aureus in critical care - Authors' reply.
door: Price, J, et al.
Gepubliceerd in: (2017)

Reply to author
door: Thao, L, et al.
Gepubliceerd in: (2018)

Management of falsepositive rifampicin resistant Xpert MTB/RIF – Authors' reply
door: Jean Claude Semuto Ngabonziza, et al.
Gepubliceerd in: (2020-10-01)

Paediatric hospital-acquired bacteraemia in developing countries reply
door: Aiken, A, et al.
Gepubliceerd in: (2012)

Prioritizing echocardiography in Staphylococcus aureus bacteraemia
door: Joseph, JP, et al.
Gepubliceerd in: (2012)

Risk stratification biomarkers for Staphylococcus aureus bacteraemia
door: Yi Cao, et al.
Gepubliceerd in: (2020-01-01)

Clinical and Microbiological Determinants of Outcome in Staphylococcus aureus Bacteraemia
door: James Price, et al.
Gepubliceerd in: (2010-01-01)

Improved outcome with early rifampicin combination treatment in methicillin-sensitive Staphylococcus aureus bacteraemia with a deep infection focus - a retrospective cohort study.
door: Erik Forsblom, et al.
Gepubliceerd in: (2015-01-01)

Metastatic Spreading of Community Acquired Staphylococcus aureus Bacteraemia
door: Giovanna Fabio, et al.
Gepubliceerd in: (2011-01-01)

Staphylococcus aureus bacteraemia cases at Helen Joseph Hospital
door: Mithra John, et al.
Gepubliceerd in: (2024-05-01)

Itraconazole or Amphotericin B for Talaromycosis. - Author Reply
door: Le, T, et al.
Gepubliceerd in: (2017)

Cost of hospitalisation for children with staphylococcus aureus bacteraemia in Western Australia
door: Miss Keerthi Anpalagan, et al.
Gepubliceerd in: (2025-03-01)

Characteristics of Staphylococcus aureus Bacteraemia and Predictors of Early and Late Mortality.
door: Matteo Bassetti, et al.
Gepubliceerd in: (2017-01-01)

Staphylococcus aureus bacteraemia in Gauteng academic hospitals, South Africa
door: Melony C. Fortuin-de Smidt, et al.
Gepubliceerd in: (2015-01-01)

Rapid Determination of Benzylpenicillin Resistance in Staphylococcus aureus Bacteraemia Model
door: Kang J, et al.
Gepubliceerd in: (2020-06-01)

Oral step-down for Staphylococcus aureus bacteraemia: An opportunity for antimicrobial stewardship?
door: Stephen Platts, et al.
Gepubliceerd in: (2022-11-01)

Methicillin-sensitive <it>Staph. aureus</it> (MSSA) and methicillin-resistant <it>Staph. aureus</it> (MRSA) bacteraemia decline simulaneously
door: Coello R, et al.
Gepubliceerd in: (2011-06-01)

Whole genome sequencing and molecular epidemiology of paediatric Staphylococcus aureus bacteraemia
door: Anita J. Campbell, et al.
Gepubliceerd in: (2022-06-01)

Risk factors for recurrence after Staphylococcus aureus bacteraemia. A retrospective matched case-control study.
door: Walker, T, et al.
Gepubliceerd in: (2009)

Impact of infectious diseases consultation on the management of Staphylococcus aureus bacteraemia in children
door: Saunderson, R, et al.
Gepubliceerd in: (2014)

Extensive remodelling of the cell wall during the development of Staphylococcus aureus bacteraemia
door: Edward JA Douglas, et al.
Gepubliceerd in: (2023-07-01)

Influence of the minimum inhibitory concentration of daptomycin on the outcomes of Staphylococcus aureus bacteraemia
door: Hajar AlQahtani, et al.
Gepubliceerd in: (2021-03-01)

Authors' reply
door: Aiken, A, et al.
Gepubliceerd in: (2012)

Allocated but not treated: the silent 16% – Authors' reply
door: Horby, P, et al.
Gepubliceerd in: (2022)

Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on in vitro Model of Staphylococcus aureus Mature Biofilm
door: Anna Gidari, et al.
Gepubliceerd in: (2020-08-01)

Low incidence of livestock-associated methicillin-resistant Staphylococcus aureus bacteraemia in The Netherlands in 2009.
door: Brigitte A G L van Cleef, et al.
Gepubliceerd in: (2013-01-01)

Authors' reply
door: Leucht, S, et al.
Gepubliceerd in: (2013)

The authors reply.
door: Schlüssel, M, et al.
Gepubliceerd in: (2013)

Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers.
door: Wertheim, H, et al.
Gepubliceerd in: (2004)

The authors reply
door: Gloyn, A, et al.
Gepubliceerd in: (2012)

Authors' reply
door: Lennox, B, et al.
Gepubliceerd in: (2012)

Author′s Reply
door: Taqi Khan, et al.
Gepubliceerd in: (2011-01-01)